• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Flexion Therapeutics, Inc. (FLXN)

    -NasdaqGM
    20.59 Down 1.07(4.94%) 4:00PM EST
    Add to Portfolio
    Prev Close:21.66
    Open:21.91
    Bid:20.59 x 300
    Ask:20.64 x 400
    1y Target Est:31.25
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:20.51 - 22.21
    52wk Range:11.06 - 24.48
    Volume:56,834
    Avg Vol (3m):86,836
    Market Cap:321.76M
    P/E (ttm):N/A
    EPS (ttm):-2.33
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for FLXN

    Comparison

    Symbol% ChgMkt Cap
    FLXNDown 4.94%321.76M
    JNJDown 2.19%280.30B
    PCRXDown 1.93%3.87B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.97
    Quarterly EPS Est (Dec-14) :-0.51
    Mean Recommendation*:1.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Flexion Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback